Navigation Links
ImmunGene Announces Multi-Target R&D Collaboration With Cephalon Australia for Interferon Payload Technology
Date:1/5/2011

THOUSAND OAKS, Calif., Jan. 5, 2011 /PRNewswire/ -- ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.

Under terms of the collaboration, Cephalon Australia will pay undisclosed fees including an up-front payment to ImmunGene for a four-year option to leverage ImmunGene's novel drug development technology in preclinical research on up to six of Cephalon Australia's drug candidates. Cephalon has the option to pay ImmunGene license fees for exclusivity on each of these candidates that it decides to move into clinical trials.

Cephalon Australia is responsible for research, clinical development, manufacturing and commercialization of products that result from the ImmunGene collaboration.  ImmunGene is eligible to receive considerable payments for research, clinical and regulatory milestones for each drug candidate in the collaboration that is commercialized, in addition to royalties on worldwide net sales of any resulting products.

Dr. Sanjay Khare, CEO of ImmunGene, said, "This collaboration is a validation of ImmunGene's novel antibody function enhancement technology that adds the power of cytokines to antibodies while reducing the systemic toxicity of the cytokines."  Dr. Raj Sachdev, ImmunGene's Chief Operating Officer, added, "We are pleased to have Cephalon Australia as a partner with its strong commitment to advancing this new class of protein therapeutics."

ImmunGene is leveraging promising science to tap the power of the immune system to develop therapeutic antibodies with increased efficacy and superior safety compared to existing therapies.

ImmunGene's breakthrough technology platform, available for non-exclusive licensing, offers phar
'/>"/>

SOURCE ImmunGene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ImmunGenes Pipeline of Next Generation Cancer Therapeutics Featured in BioWorld Today
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... Spanje, July 4, 2015 ... aan eerstelijns chemotherapie voor patiënten met niet-resectabele ... verlengt de progressievrije overleving in dat orgaan. ... colorectale kanker (mCRC) die alleen binnen de ... in progressievrije overleving (PFS) in de lever ...
(Date:7/3/2015)... 2015 Un fournisseur mondial ... sont l,hypertension, le diabète et les troubles thyroïdiens ... gratuites et d,une conférence majeure dédiée à ces ... ) , Les formations Prendre ... Prendre en charge l,hypertension en ligne et ...
(Date:7/2/2015)... , July 3, 2015 ... del 100% de participación en ZAO "Biocom" en ... marca la incursión de Lupin en el mercado ... RUB en ventas, colocándolo como uno de los ... (IMS Health). Durante más de una década, el ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... Oct. 4 Re-opening a blocked heart artery isn,t ... instruments through an opening in a thigh artery and ... is also a concern. (Logo: ... Arteriotomy — the process of creating a hole ...
... (Nasdaq: GPRO ) announced today that the ... Food and Drug Administration (FDA) for its APTIMA® ... system. "Trichomonas is the most common curable ... lead to serious health consequences if left untreated," said ...
Cached Medicine Technology:Guidelines on Using Artery-Closing Devices: Devices Are OK, But More Research Needed 2Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis 2Gen-Probe Files US Regulatory Application for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis 3
(Date:7/3/2015)... ... July 03, 2015 , ... On June 30th SEO ... SEO training system called "Page One Engine" . The program, which has ... glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and ... 2016 Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, ... held at the Westin Galleria Dallas. , Designed to take participants from the basic ...
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
(Date:7/3/2015)... ... 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director of ... of independent freestanding emergency rooms in the United States. , “We are excited to ... said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Yisrayl Hawkins, Pastor ... article this week that he says will reveal biblical truth and expose popular lies ... Does Your Bible Say Don’t Have Sex”, immediately goes into the core of the ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2
... who played with a limited number of toys showed ... than those receiving other community-based treatments. The ... called Hanen,s More Than Words for children ... spectrum disorder. Caught early enough and treated with the ...
... , MONDAY, March 21 (HealthDay News) -- ... need a Pap test or not, says the American ... released its updated recommendations for women,s annual routine ob-gyn ... health assessments are grouped by age range, starting with ...
... HealthDay Reporter , MONDAY, March 21 (HealthDay News) ... facelifts, Botox injections, nose jobs and liposuction than ever before. ... Surgeons shows that the number of cosmetic procedures among men ... compared with 2009. Men underwent more than 1.1 million ...
... MONDAY, March 21 (HealthDay News) -- The American Heart Association ... life-threatening blood clots that form in the legs, deep veins ... to the lungs, causing a pulmonary embolism, which can be ... 250,000 people are hospitalized for deep vein thrombosis, whose symptoms ...
... Rockville, Md., March 21, 2011 As part of ... Pharmacopeial Convention (USP) is working with the Food and ... (CHPA) to update quality standards for widely used medicines ... an ambitious, long-term effort to assess written (or documentary) ...
... given a $3.9 million grant to Carnegie Mellon University,s ... further the development of novel biomedical tools targeted at ... will allow the interdisciplinary team of researchers to advance ... and treating disease. These include the development of ...
Cached Medicine News:Health News:Interest in toys predicts effectiveness of autism treatment in toddlers 2Health News:Interest in toys predicts effectiveness of autism treatment in toddlers 3Health News:Women Should See Ob-Gyn Annually, Experts Say 2Health News:Pressure to Look Young May Be Sending More Men to Plastic Surgeons 2Health News:Pressure to Look Young May Be Sending More Men to Plastic Surgeons 3Health News:Severe Blood Clots Should be Treated Aggressively: Heart Docs 2Health News:Severe Blood Clots Should be Treated Aggressively: Heart Docs 3Health News:Quality standards for widely used medicines strengthened 2Health News:Quality standards for widely used medicines strengthened 3Health News:DSF Charitable Foundation gives $3.9M to CMU's Center or Nucleic Acids Science & Technology 2Health News:DSF Charitable Foundation gives $3.9M to CMU's Center or Nucleic Acids Science & Technology 3
... the Finntip Wide is designed especially for ... genomic DNA. This tip eliminates the mechanical ... excellent for use with extremely viscous liquids. ... of the orifice is 1.1 mm or ...
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels...
... have been designed to optimize the accuracy ... our tip products is widely recognized by ... has been extended over the years and ... and special tips including filter tips, certified ...
The Ultra Micro tip for the Eppendorf and Nichiryo/BenchMate 0.5-10 L pipettors is perfect for working with low volume samples....
Medicine Products: